Assessment of coronavirus disease 2019 severity in hospitalized pediatric patients with atopic dermatitis: a case‒control study

Introduction: The Centers for Disease Control and Prevention has included asthma as a risk factor for developing severe coronavirus disease 2019 (COVID-19) illness. Respiratory viruses are known to run a more severe course in patients with underlying respiratory illnesses. However, the reports on th...

Full description

Bibliographic Details
Main Authors: Alpana Mohta, Bhikam Chand Ghiya, Rajesh Dutt Mehta, Vijeta Prasad
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2022-01-01
Series:Indian Journal of Paediatric Dermatology
Subjects:
Online Access:http://www.ijpd.in/article.asp?issn=2319-7250;year=2022;volume=23;issue=2;spage=123;epage=125;aulast=Mohta
_version_ 1819022630831783936
author Alpana Mohta
Bhikam Chand Ghiya
Rajesh Dutt Mehta
Vijeta Prasad
author_facet Alpana Mohta
Bhikam Chand Ghiya
Rajesh Dutt Mehta
Vijeta Prasad
author_sort Alpana Mohta
collection DOAJ
description Introduction: The Centers for Disease Control and Prevention has included asthma as a risk factor for developing severe coronavirus disease 2019 (COVID-19) illness. Respiratory viruses are known to run a more severe course in patients with underlying respiratory illnesses. However, the reports on the association of atopic dermatitis and COVID-19 infection are contrasting. Aims and Objectives: We aimed at assessing the difference between the severity of COVID-19 illness in patients having concurrent atopic dermatitis compared to those without concurrent atopic dermatitis. Materials and Methods: Study subjects included real-time polymerase chain reaction (RT-PCR) positive COVID-19 patients under the age of 18 years. The patients were divided into two groups, namely, cases and controls. Cases included children with atopic dermatitis diagnosed according to revised Hanifin and Rajka criteria with positive COVID-19 RT-PCR report. Controls were age-and sex-matched children from the same center with COVID-19, without atopic dermatitis. Disease severity was compared between the two groups. In addition, the COVID-19 severity was correlated with the SCORAD in the "cases" group. Results: While assessing the severity of COVID-19 illness on the basis of computed tomography score and clinical severity, there was a higher proportion of "severe" illness in "cases" compared to "controls," however, the difference was statistically insignificant. There was no significant correlation between high SCORAD scores and severe COVID-19 illness. Conclusion: Our study contributes to the ever-growing data suggesting that atopic diathesis is not a risk factor for acquiring COVID-19.
first_indexed 2024-12-21T04:26:03Z
format Article
id doaj.art-f99c208beec241179cd7405e7fb56af9
institution Directory Open Access Journal
issn 2319-7250
language English
last_indexed 2024-12-21T04:26:03Z
publishDate 2022-01-01
publisher Wolters Kluwer Medknow Publications
record_format Article
series Indian Journal of Paediatric Dermatology
spelling doaj.art-f99c208beec241179cd7405e7fb56af92022-12-21T19:16:04ZengWolters Kluwer Medknow PublicationsIndian Journal of Paediatric Dermatology2319-72502022-01-0123212312510.4103/ijpd.ijpd_147_21Assessment of coronavirus disease 2019 severity in hospitalized pediatric patients with atopic dermatitis: a case‒control studyAlpana MohtaBhikam Chand GhiyaRajesh Dutt MehtaVijeta PrasadIntroduction: The Centers for Disease Control and Prevention has included asthma as a risk factor for developing severe coronavirus disease 2019 (COVID-19) illness. Respiratory viruses are known to run a more severe course in patients with underlying respiratory illnesses. However, the reports on the association of atopic dermatitis and COVID-19 infection are contrasting. Aims and Objectives: We aimed at assessing the difference between the severity of COVID-19 illness in patients having concurrent atopic dermatitis compared to those without concurrent atopic dermatitis. Materials and Methods: Study subjects included real-time polymerase chain reaction (RT-PCR) positive COVID-19 patients under the age of 18 years. The patients were divided into two groups, namely, cases and controls. Cases included children with atopic dermatitis diagnosed according to revised Hanifin and Rajka criteria with positive COVID-19 RT-PCR report. Controls were age-and sex-matched children from the same center with COVID-19, without atopic dermatitis. Disease severity was compared between the two groups. In addition, the COVID-19 severity was correlated with the SCORAD in the "cases" group. Results: While assessing the severity of COVID-19 illness on the basis of computed tomography score and clinical severity, there was a higher proportion of "severe" illness in "cases" compared to "controls," however, the difference was statistically insignificant. There was no significant correlation between high SCORAD scores and severe COVID-19 illness. Conclusion: Our study contributes to the ever-growing data suggesting that atopic diathesis is not a risk factor for acquiring COVID-19.http://www.ijpd.in/article.asp?issn=2319-7250;year=2022;volume=23;issue=2;spage=123;epage=125;aulast=Mohtaasthmaatopic dermatitiscoronavirus disease 2019pediatric coronavirus disease 2019severe acute respiratory syndrome-coronavirus-2
spellingShingle Alpana Mohta
Bhikam Chand Ghiya
Rajesh Dutt Mehta
Vijeta Prasad
Assessment of coronavirus disease 2019 severity in hospitalized pediatric patients with atopic dermatitis: a case‒control study
Indian Journal of Paediatric Dermatology
asthma
atopic dermatitis
coronavirus disease 2019
pediatric coronavirus disease 2019
severe acute respiratory syndrome-coronavirus-2
title Assessment of coronavirus disease 2019 severity in hospitalized pediatric patients with atopic dermatitis: a case‒control study
title_full Assessment of coronavirus disease 2019 severity in hospitalized pediatric patients with atopic dermatitis: a case‒control study
title_fullStr Assessment of coronavirus disease 2019 severity in hospitalized pediatric patients with atopic dermatitis: a case‒control study
title_full_unstemmed Assessment of coronavirus disease 2019 severity in hospitalized pediatric patients with atopic dermatitis: a case‒control study
title_short Assessment of coronavirus disease 2019 severity in hospitalized pediatric patients with atopic dermatitis: a case‒control study
title_sort assessment of coronavirus disease 2019 severity in hospitalized pediatric patients with atopic dermatitis a case control study
topic asthma
atopic dermatitis
coronavirus disease 2019
pediatric coronavirus disease 2019
severe acute respiratory syndrome-coronavirus-2
url http://www.ijpd.in/article.asp?issn=2319-7250;year=2022;volume=23;issue=2;spage=123;epage=125;aulast=Mohta
work_keys_str_mv AT alpanamohta assessmentofcoronavirusdisease2019severityinhospitalizedpediatricpatientswithatopicdermatitisacasecontrolstudy
AT bhikamchandghiya assessmentofcoronavirusdisease2019severityinhospitalizedpediatricpatientswithatopicdermatitisacasecontrolstudy
AT rajeshduttmehta assessmentofcoronavirusdisease2019severityinhospitalizedpediatricpatientswithatopicdermatitisacasecontrolstudy
AT vijetaprasad assessmentofcoronavirusdisease2019severityinhospitalizedpediatricpatientswithatopicdermatitisacasecontrolstudy